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Abstract:  
 
Patterns of mental health (MH) and substance abuse (SA) treatment utilization among 
populations receiving services through multiple public programs are not well known. This study 
examines to what extent populations with MH and/or SA conditions utilize treatment services 
through Medicaid and State MH/SA Agencies. Data are from the Substance Abuse and Mental 
Health Services Administration Integrated Database, a multiyear file for 3 states combining 
Medicaid and State MH/SA Agency administrative data into a uniform database. Although 
populations with co-occurring conditions and those served by both Medicaid and State MH/SA 
Agencies have substantial contact with the public treatment system, a majority of the MH/SA 
populations examined here utilize few services over brief periods of time. Utilization is most 
limited among individuals with MH-only conditions and those served exclusively by Medicaid. 
While a lack of data on clinical outcomes prevents us from drawing conclusions about the 
effectiveness of MH/SA services, results of this analysis indicate that public programs in the 
states examined here do not provide services that are primarily utilized on a frequent or chronic 
basis. 
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Article:  
 
Introduction  
 
A common belief among many healthcare professionals is that individuals with mental health 
and/or substance abuse (MH/SA) conditions utilize treatment services frequently over long 
periods of time. Studies suggest, however, that the majority of privately insured individuals 
utilize relatively few behavioral health services over brief, discrete periods of time)1-8 Cohen and 
Cohen 9 refer to the discrepancy between the perceived and actual use of MH/SA services as the 
"clinician's illusion," whereby long-term patients dominate clinicians' time, use the vast majority 
of services, and thus create an unrepresentative impression of the general MH/SA population 
with regard to treatment frequency and duration. Moreover, characterizations that MH/SA 
populations remain in public treatment for long periods of time do not support the recovery-
based approach in both the MH and SA fields--that persons seeking MH/SA services often 
receive effective treatment and do not need treatment chronically.10,ll  
 
Although limited service utilization has been shown for Medicaid beneficiaries with MH 
conditions, 12 few studies have examined the use of MH/SA services among populations covered 
by multiple public agencies. The lack of research on these populations is due primarily to limited 
data. Because state organizations managing the delivery of MH/SA services often operate in 
isolation of one another, information about MH/SA service utilization resides with each 
individual agency. 13 Databases containing information on individuals receiving MH/SA services 
through multiple public agencies are therefore rare and typically incomplete. Fragmented data 
have impeded the efforts of researchers and policymakers to determine whether service 
utilization varies between public agencies and between individuals with single and co-occurring 
MH/SA conditions. Such information may greatly benefit state policymakers in making difficult 
decisions about the distribution of scarce resources for the provision of MH/SA services.  
 
The purpose of this study is to describe patterns of utilization of MH/SA treatment services 
provided through Medicaid and State MH/SA Agencies. A unique data source, the Integrated 
Database (IDB), is used to examine the length of time MH/SA patients in 3 states remain in the 
public treatment system, how often they utilize services, and through which agencies (Medicaid, 
State Agencies, or both) they receive services over a 3-year study period. This study also 
examines to what extent service utilization varies between individuals with single or both MH 
and SA conditions. To the authors' knowledge, this study is the first to present this information 
for populations receiving MH/SA services through multiple public agencies over a multiyear 
period. 
 
Data and Methods 
 
Overview 
 
To address the lack of complete information on populations receiving public MH/SA services, 
the Substance Abuse and Mental Health Services Administration (SAMHSA) initiated an effort 
in 1996 to integrate disparate sources of data on MH/SA services. The result of this effort, the 
IDB, assembles information from 3 types of state organizations: State Medicaid programs, State 
MH Agencies, and State SA Agencies. The IDB links service record information on MH/SA 
treatment utilization for each person into a uniforrn database. Because the IDB combines 
information for individuals who receive services under multiple public programs, the IDB thus 
provides a more complete picture of the MH/SA clients seen in more than 1 part of the state-
supported MH/SA treatment system. The IDB contains person- and service-level data for all such 
clients within a state (for a full description of the methodology used to link IDB service records 
across state organizations, see Whalen et all4). 
 
The IDB contains administrative service records for individuals receiving public MH/SA 
services through Medicaid and/or State MH/SA Agencies and encompasses 3 full calendar years 
(1996- 1998) for 3 states: Delaware, Oklahoma, and Washington. The 3 participating states were 
chosen on the basis of their availability of electronic data, the ability of their data systems to link 
clients across agencies, and state interest in the IDB project. The IDB also contains information 
on patient demographics, such as age, sex, race, and urban/rural location, as well as information 
on Medicaid eligibility status, MH/SA diagnosis codes, providers, and Medicaid drug 
prescriptions and other Medicaid medical records. 
 
Study population 
 
The study population for this analysis consists of individuals who had a primary MH or SA 
diagnosis or who received any MH or SA service during the study period. MH/SA diagnoses are 
defined using codes on the basis of the International Classification of Diseases, 9th Revision, 
Clinical Modification (ICD-9-CM). MH/SA diagnoses are identified using ICD-9-CM codes 
listed in Coffey et al.3 Clients with missing diagnoses were selected for the study population on 
the basis of evidence of having received an MH/SA service. MH/SA service categories were 
created using several criteria, including source of record and service description, 13 After 
identifying the study population on the basis of diagnosis or use of service, persons older than 64 
years and persons who changed age category (youth to adult or adult to elderly) during the study 
period are excluded. Excluding persons older than 64 years eliminates 7.9% of all clients in the 
IDB study population while exclusion of persons who changed age category eliminates an 
additional 1.2%. After making these exclusions, roughly 70% of the study population in each 
state is classified as adult (ages 18 to 64 years), with the remaining 30% classified as youth (ages 
less than 18 years). 
 
Beginning in 1998, State MH Agency records from Washington did not include information on 
specific outpatient service dates, but rather only the month of service and the number of service 
encounters within a month. As a result, encounter dates are evenly assigned to individuals within 
each month to approximate service use patterns similar to those seen in 1996 and 1997. Although 
this method does not reflect the true date-specific service use of Washington service users in 
1998, it is more realistic than the alternative of assigning all observed encounters within a month 
to a single date. Service encounter dates created in this manner account for roughly 35% of all 
MH/SA service dates from Washington across the 3-year study period. 
 
Client classification 
 
Individuals included in the analysis are classified and examined on 2 major domains: (1) service 
agency and (2) MH/SA category. Service agency refers to the data source (Medicaid or State 
MH/SA Agency) from which each IDB record was obtained and allows us to generally identify 
individuals who receive MH/SA services through Medicaid only, through State Agencies only, 
or through both Medicaid and State Agencies. Individuals classified as having MH/SA service 
records in both Medicaid and State Agency databases, however, do not necessarily receive 
services through both auspices concurrently. A client with one Medicaid record at the beginning 
of the study period and one State Agency record at the end of the study period, for example, is 
classified as having received services through both auspices. In some cases, the same MH/SA 
service record appears on both the Medicaid and State Agency databases. Overlapping records 
may occur if Medicaid reimburses a bill but the State Agency provides the service. To avoid 
overstating utilization rates, only one service date is counted for cases in which a service user, 
provider, service, and service date are reported on both the Medicaid and State Agency 
databases. Additionally, individuals with these types of records are classified as receiving 
services through both Medicaid and State Agencies (for further information on the reconciliation 
of overlapping service records in the IDB, see Coffey et al 13). 
 
The second domain on which individuals are classified and analyzed is MH/SA category, which 
is used to identify individuals who had services for only MH conditions (MH-only), only SA 
conditions (SA-only), or co-occurring (both MH and SA) conditions during the study period. 
Service users are assigned to MH-only and SA-only categories on the basis of primary diagnosis, 
but secondary diagnostic information was considered for co-occurring conditions. Individuals are 
classified as having co-occurring conditions if they had any of the following within the 3-year 
study period: (1) both a primary MH and SA diagnosis, (2) a primary MH and secondary SA 
diagnosis, or (3) a primary SA and secondary MH diagnosis. In the absence of diagnosis 
information, MH-only and SA-only classifications were assigned on the basis of the type of 
service received during the study period. For cases in which diagnosis information was not 
available, individuals were classified as having co-occurring conditions on the basis of evidence 
of receiving both an MH and SA service. Individuals classified as having co-occurring 
conditions did not necessarily have MH and SA conditions concurrently. A client with an MH 
record at the beginning of the study period and an SA record at the end of the study period, for 
example, is classified as having co-occurring conditions. 
 
Individuals served exclusively by Medicaid make up 20% to 40% of the study population across 
all 3 states, whereas 45% to 66% are served exclusively by State Agencies. The proportion of 
individuals served by both Medicaid and State Agencies varies from 12% to 36% across the 3 
states. Most service users (55%-70% across all 3 states) in the study population are classified as 
MH-only, while a much smaller proportion of clients (16%-28%) are classified as SA-only. 
Individuals classified as having co-occurring conditions make up 10% to 17% of the study 
population across all 3 states. 
 
Utilization measures 
 
Medians and frequency distributions of individuals' length of service window, number of total 
MH/SA encounter dates, and frequency of MH/SA service use are presented to examine the level 
of contact individuals in the study population have with the public treatment system. A service 
window is defined as the number of days between an individual's first and last observed MH/SA 
service record during the 3-year study period. An individual's total number of service encounter 
dates is defined as the count of unique dates over the entire study period on which they had an 
administrative record with at least 1 MH/SA diagnosis or service. Service encounter dates 
occurring within a single inpatient stay are considered to be distinct and separate encounter 
dates. 
 
To present a more comprehensive picture of public MH/SA service utilization, the concepts of 
service window length and number of encounter dates are combined to create 4 mutually 
exclusive categories of service utilization: (1) single encounter date, (2) short-term, (3) 
occasional, and (4) frequent utilizers of the public MH/SA treatment system. Single encounter 
date utilizers are defined as persons with only 1 encounter date during the entire study period. 
Short-term utilizers are defined as individuals with a service window of 3 months or less but 
more than 1 encounter date. Occasional utilizers are defined as those with a service window 
greater than 3 months but fewer than 10 encounter dates. Frequent utilizers are defined as 
persons with a service window greater than 3 months and 10 or more encounter dates. 
 
Results are presented for each state side-by-side to aid readers' comprehension of state-specific 
results and to identify within-state trends that appear similar across the 3 states. However, 
comparisons of MH/SA utilization between states should not be made because state programs 
managing the delivery of MH/SA services differ in many dimensions (eg, MH/SA program 
financing, organization, benefits, provider payment arrangements, available settings for care, and 
provider networks). For further information on the organizational framework of MH/SA service 
delivery in each state, see Coffey et al. 13 
 
Results 
 
Because the IDB spans a 3-year period, individuals appear in the database in different years and 
for varying lengths of time. A basic but important result of this analysis is that the majority of 
MH/SA service users (between 60% and 73% across all 3 states) appear in the IDB during 1 and 
only 1 year of the study period, while a much smaller proportion of individuals (11%-17%) 
appear in all 3 years. Between 14% and 20% of service users across all 3 states have MH/SA 
service records in 2 consecutive years of the study period, while a very small proportion of 
individuals (less than 3% across all 3 states) have service records in 1996 and 1998 but no 
records in 1997. These results are consistent with patient tumover rates estimated in other studies 
of Medicaid populations (eg, reference 15). 
 
Length of service window 
 
Table 1 presents the distribution of service windows and suggests that the majority of MH/SA 
service users in the states examined here have relatively brief contact with the public treatment 
system. Half of all MH/SA service users in each state, for example, are present in the treatment 
system for 139 days or less over a 3-year period while one quarter of all individuals has service 
windows of 8 days or less. Contact with the treatment system is particularly brief for those 
served exclusively by Medicaid, as one quarter of these individuals have a service window of 
only 1 day. Persons receiving services through both Medicaid and State Agencies, however, 
appear to have a substantially longer period of contact with the treatment system than those 
receiving services through Medicaid or State Agencies alone. Among all service users, for 
example, 50% of those receiving services through both auspices have a service window of at 
least 344 days compared to only 135 days for individuals served by Medicaid alone or by State 
Agencies alone. 
 
Table 1 also indicates that service window length varies by MH/SA category. Individuals with 
co-occurring conditions, for example, generally have a lengthy service window (ranging from 
302 to 465 days at the median across all 3 states) and remain in treatment more than 4 times 
longer (at the median) than individuals with single MH or SA conditions. For individuals with 
MH-only conditions, however, contact with the treatment system is particularly brief as one 
quarter of these individuals in each state are present in the treatment system for only 1 day. 
Finally, individuals with MH-only conditions in 2 states have a shorter period of contact with the 
treatment system at the median than SA-only service users. 
 
Total service encounter dates 
 
Table 2 presents the distribution of total service encounter dates. Half of all service users in each 
state have 12 or fewer MH/SA service dates over the 3-year study period. While individuals 
served by both Medicaid and State Agencies have the greatest number of encounter dates over 
the study period, those served exclusively by Medicaid appear to have the fewest. Low intensity 
of utilization among Medicaid-only service users is further pronounced in that 75% of these 
individuals across the 3 states have fewer than 23 encounter dates over the 3-year study period. 
 
Table 2 also shows that the number of service dates varies by MH/SA category. As expected, 
individuals with co-occurring conditions have a higher median number of service encounter 
dates than those with a single MH or SA condition. Individuals with co-occurring conditions in 
each state, for example, have at least 20 more service dates at the median than those with MH-
only conditions and at least 11 more at the median than those with SA-only conditions. 
Moreover, 3 quarters of individuals with co-occurring conditions have at least 8 encounter dates 
over the study period, and in 2 states 3 quarters of individuals with SA-only conditions have at 
least 6 encounter dates. Additionally, MH-only patients in 2 states have at least 20 fewer 
encounter dates at the median than those with SA-only conditions. Limited utilization among 
MH-only service users relative to those with both co-occurring and SA-only conditions is further 
pronounced in that one quarter of all MH-only service users in each state have only 1 service 
encounter date over the study period. When MH-only patients are served by both Medicaid and 
State Agencies, however, service encounter dates for this group rise substantially (to at least 11 
encounter dates) in 2 of the 3 states. 
 
 
 
 
 
Levels of MH/SA service utilization presented in Table 2 are somewhat lower than those found 
at the national level in previous studies. Two recent studies by Olfson et al, 16,17 for example, 
examined national trends in outpatient treatment for depression and found that adults and 
adolescents had on average 8 to 9 annual encounters for depression over the 1996-1999 period. 
While still brief in duration, the number of annual behavioral health encounters found by Olfson 
et al is somewhat higher than the 3-year levels found in the IDB. 
 
MH/SA service utilization categories 
Table 3 combines the concepts of service window length and number of encounter dates to 
classify MIMSA patients in the study population into 4 mutually exclusive categories. These 
categories consist of single encounter utilizers (individuals with a single encounter date), short-
term utilizers (individuals with a service window of 3 months or less), occasional utilizers 
(individuals with a service window greater than 3 months, but less than 10 encounter dates), and 
frequent utilizers (individuals with a service window greater than 3 months and more than 10 
encounter dates). Table 3 presents the percentage of individuals in the study population that fall 
into each category. 
 
Additional evidence presented in Table 3 suggests that the majority of MH/SA service users in 
the states examined here do not receive frequent care over long periods of time. Specifically, a 
substantial proportion of all MH/SA service users (at least 18% across all 3 states) have only 1 
service encounter date over the entire 3-year study period. Additionally, after combining single 
encounter and short-term utilizers, roughly half of all persons (44%-54% across all 3 states) are 
in the public treatment system for 3 months or less. 
 
Table 3 also provides additional evidence that individuals served by both Medicaid and State 
Agencies have the most contact with the public treatment system while those served by only 
Medicaid have the least contact. Across all 3 states, for example, roughly 65% to 81% of 
individuals served by both auspices are classified as frequent utilizers while only 5% or less are 
classified as single encounter utilizers. In contrast, only 35% or less of individuals served by 
Medicaid only across all 3 states are frequent utilizers while as many as 52% of individuals 
served exclusively by Medicaid have only a single encounter date. 
 
Finally, Table 3 provides further evidence supporting the finding that individuals with co-
occurring conditions have substantially more contact with the public treatment system than 
individuals with single MH or SA conditions. Specifically, individuals with co-occurring 
conditions are less likely to have a single encounter date and are more likely to be frequent 
utilizers of public MH/SA services than individuals with MH-only or SA-only conditions. 
Results presented in Table 3 also support the finding that SA-only service users generally have 
greater contact with the public treatment system than MH-only service users. In 2 states, for 
example, those with SA-only conditions are substantially less likely to have only a single 
encounter date over the 3-year study period than those with MH-only conditions. Moreover, 
roughly half of all individuals with SA-only conditions in 2 states are classified as frequent 
utilizers compared to only one third of MH-only service users classified as frequent utilizers 
during the 3-year study period. 
 
Sensitivity analysis 
 
Service window and encounter date distributions presented in Tables 1 and 2 are potentially 
inflated as a result of individuals who are institutionalized or receive services in an inpatient or 
other long-term setting. Tables 1 and 2 were reproduced (available upon request from the 
authors) excluding those who received treatment in long-term settings and found only a minimal 
decrease in the median and upper percentiles of service window length and total encounter dates. 
The potentially confounding effect of long-term service users is therefore quite small. 
 
 
 
Tables 1 to 3 were also reproduced separately for youths (ages 0-17 years) and adults (ages 18- 
64 years) to detect differences in service utilization by age. Service window length and number 
of total encounter dates were found to be lower among youths than among adults. In 2 states, 
youths were also found to be more likely to have a single encounter date and less likely to be 
frequent utilizers of public MH/SA services. Utilization among individuals served by Medicaid 
alone, however, was found to be higher for youths than for adults, a result that may reflect the 
youth-specific focus of many outreach initiatives implemented by state Medicaid programs. 
 
Limitations 
 
Results presented in this article should be interpreted with caution, as this study has several 
limitations. First, comparisons of service utilization between states should not be made because 
the organizational framework and policies under which services are delivered vary considerably 
across the states. Second, the limited time frame of the IDB prevents us from observing data on 
individuals who utilized MH/SA services either before 1996 or after 1998. As a result, it is 
possible that some individuals who appear in the treatment system briefly at the beginning or end 
of the study period are in fact high utilizers of MH/SA services but are not captured as so in the 
3-year window. A third limitation of this study is that information on prescription drug 
utilization is not considered. It is thus possible that some individuals in the study population have 
few encounters because they are receiving treatment in the form of a medication-based 
maintenance program. Finally, because this analysis focuses on only discrete events of service 
utilization without respect to clinical MH/SA outcomes or prevalence and severity of MH/SA 
conditions, conclusions about the adequacy of treatment services provided in the states examined 
here cannot be drawn. Despite these limitations, results presented in this study have important 
implications that may aid states in the delivery and management of public MH/SA services. 
 
Implications for Behavioral Health 
 
Previous studies have shown that privately insured MH/SA patients generally receive few 
treatment services over brief periods of time. 1-8 Results of this analysis indicate a similar pattern 
for individuals receiving MH/SA services through multiple public agencies. These results may 
support those from previous studies that promote a recovery model--that persons seeking MH/SA 
services often receive effective treatment and therefore do not need treatment on a continual 
basis. While a lack of data on clinical outcomes prevents us from drawing conclusions about the 
effectiveness of MH/SA services, the results do indicate that public treatment programs in the 
states examined here do not primarily provide services that are utilized on a frequent or chronic 
basis. 
 
The results presented in this study also indicate that MH/SA service use varies across funding 
agencies, as individuals served by both Medicaid and State Agencies have substantial contact 
with the treatment system while those served only by Medicaid have very limited contact. 
Specifically, individuals served by both Medicaid and State Agencies are generally the most 
likely to be frequent utilizers and the least likely to have a single encounter date while those 
served by Medicaid alone are the most likely to have a single encounter date and the least likely 
to be frequent utilizers. 
 
A major implication of the results presented here relates to the general finding that the majority 
of the MH/SA populations in the states examined here display limited use of public MH/SA 
services over brief periods of time. Given such transitory patterns of service use, it is likely that 
state organizations managing the delivery of MH/SA services are not funding treatment of the 
same individuals from year to year. While most individuals do not remain engaged in public 
treatment from year to year, they appear much more likely to do so when they have co-occurring 
conditions. Service use among clients with MH-only conditions was shorter than that for those 
with co-occurring conditions but still of significant duration. With little data on the severity of 
client conditions, it is difficult to determine whether the level of service use observed here is 
adequate for favorable client outcomes. 
 
Analysis results also indicate that treatment utilization for individuals with SA-only conditions 
was more intense for a brief initial period of time, but continuity of services after the initial time 
period was relatively absent. Greater intensity of initial service use is encouraging, as it may 
indicate successful treatment engagement. The lack of subsequent treatment utilization after an 
initial period of intense service use among clients with SA-only conditions may be the result of 
several factors that cannot be detected in the IDB data, including patient follow-up with 
nonbilling services such as Alcoholics Anonymous. Given the relapsing nature of addictions, 
however, the lack of continuing care observed in this study may raise the possibility that needed 
services are not being utilized and further study is thus warranted. 
 
The generally limited level of treatment utilization among the MH/SA populations examined 
here may be the result of several factors that have not been accounted for, such as state-specific 
managed care restrictions18 or participation in Aid to Families with Dependent Children or 
Temporary Assistance for Needy Families (TANF), criminal justice programs, nonbilling 
programs such as Alcoholics Anonymous, or other Federal programs that provide resources for 
the use of medical services. It is also unclear what effect evaluation and consultation visits have 
on utilization rates. Preliminary analyses suggest that evaluation visits may account for a 
substantial number of the single encounter date utilizers observed in this study. It may also be 
possible that some MH/SA patients require fewer service encounters because of participation in 
medication-based maintenance programs in addition to therapy. To the extent that a combination 
of medication and therapy is more efficacious than either treatment alone,19-21 short treatment 
durations and few encounter dates may be the preferred scenario among clinicians and 
policymakers. Investigating the impact of managed care penetration, participation in other 
Federal programs, the use of medications, and other factors on MH/SA service use is an 
important direction for future studies. 
 
An additional implication relates to the interpretation given to the lower levels of treatment 
utilization found among individuals served by Medicaid alone. Specifically, differences in 
utilization between Medicaid and State Agencies may in part be accounted for by differences in 
the populations covered. For instance, Medicaid populations have a large number of TANF-
eligible families who access MH/SA services at a lower rate and may need only 1 or a few 
service encounter dates in the public specialty treatment system. Low utilization among those 
served only by Medicaid may also be the result of Medicaid providers engaging State MH/SA 
Agencies for individuals with more intensive treatment needs. Low utilization among Medicaid-
only service users may also reflect differences in the types of services covered under Medicaid. 
Moreover, low utilization among Medicaid-only service users may be even less of a concern 
considering the relatively high rate of utilization found among individuals receiving services 
through both Medicaid and State Agencies. 
 
Finally, results of this analysis also indicate that individuals with co-occurring conditions have a 
higher level of contact with the public MH/SA treatment system than those with only MH or 
only SA conditions, and those with SA-only conditions have higher levels of service use than 
those with MH-only conditions. It is reassuring to find, however, that individuals who are 
potentially the most severely ill (eg, those with co-occurring conditions) have more extensive 
contact with the public treatment system than individuals with a single MH or SA condition. 
 
Although several important findings are presented in this article, further research is needed to 
gain a more complete understanding of the delivery, financing, and utilization of public sector 
MH/SA service utilization. In light of previous research documenting the cost offsets associated 
with both MH and SA treatment (references 22 and 23, respectively), one area of future research 
would be to examine the subsequent general healthcare utilization of clients in the IDB. The IDB 
is a unique and rich data source that may support such studies. 
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